Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. EGFR inhibitors as first-line therapy in advanced non-small cell lung cancer
Your Article Summary
See Latest ArticlesLL-37 Complexation with Glycosaminoglycans in Cystic Fibrosis Lungs Inhibits Antimicrobial Activity, Which Can Be Restored by Hypertonic Saline
Journal of Immunology, 06/30/09
Bergsson G et al. - Data suggest glycosaminoglycan–LL-37 complexes to be potential therapeutic targets. Factors that disrupt glycosaminoglycan–LL-37 aggregates promote the antimicrobial effects of LL-37 with the caveat that concomitant administration of antiproteases may be needed to protect the now liberated LL-37 from proteolytic cleavage.
Today in Cystic Fibrosis...keeping you current
Receive free subspecialty "5-minute updates" via email
Prevalence and outcome of pulmonary fibrosis in microscopic polyangiitis
European Respiratory Journal , 11/24/09
Continuous vs Thrice-Daily Ceftazidime for Elective Intravenous Antipseudomonal Therapy in Cystic Fibrosis
Infection, 09/22/09
Lung Transplantation in Patients with Cystic Fibrosis
Seminars in Respiratory and Critical Care Medicine, 09/17/09
Sponsor
Article Search
Sponsor